Quick Answer
Corvus Pharmaceuticals, Inc. reported Cash And Cash Equivalents At Carrying Value of $4.58 million for the year ending 2025.
- Corvus Pharmaceuticals, Inc. showed a decrease of -47.6% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from Corvus Pharmaceuticals, Inc.'s annual report (Form 10-K), filed with the SEC on March 12, 2026.
- XBRL data for this metric is available from 2014 to 2025 (12 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2015: $13.91 million | Q2 2015: $2.65 million | Q3 2015: $79.60 million | Q1 2016: $4.07 million | Q2 2016: $4.34 million | Q3 2016: $5.58 million | Q4 2016: $5.05 million | Q1 2017: $10.49 million | Q2 2017: $34.10 million | Q3 2017: $44.10 million | Q1 2018: $102.57 million | Q2 2018: $28.07 million | Q3 2018: $40.75 million | Q1 2019: $38.98 million | Q2 2019: $30.18 million | Q3 2019: $9.07 million | Q1 2020: $23.50 million | Q2 2020: $20.71 million | Q3 2020: $22.98 million | Q1 2021: $45.10 million | Q2 2021: $58.92 million | Q3 2021: $72.30 million | Q1 2022: $31.46 million | Q2 2022: $28.48 million | Q3 2022: $24.59 million | Q1 2023: $9.65 million | Q2 2023: $7.66 million | Q3 2023: $20.11 million | Q1 2024: $7.46 million | Q2 2024: $14.84 million | Q3 2024: $4.68 million | Q1 2025: $5.00 million | Q2 2025: $14.69 million | Q3 2025: $2.87 million.
- Over the full 12 years of available data (2014 to 2025), Corvus Pharmaceuticals, Inc.'s Cash And Cash Equivalents At Carrying Value has declined by 63.4%.
- Historical annual values: Fiscal year 2025: $4.58 million | Fiscal year 2024: $8.74 million | Fiscal year 2023: $12.62 million | Fiscal year 2022: $13.16 million | Fiscal year 2021: $63.46 million | Fiscal year 2020: $16.46 million | Fiscal year 2019: $5.15 million | Fiscal year 2018: $39.20 million | Fiscal year 2017: $45.11 million | Fiscal year 2016: $5.05 million | Fiscal year 2015: $4.11 million | Fiscal year 2014: $12.52 million.
- Data sourced from SEC EDGAR public filings as of August 10, 2026.
Last verified: